Compare Transocean Ltd (RIG) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Transocean Ltd vs Revvity Inc — how do they compare? Transocean Ltd trades at $5.32 (market cap $5.80B), while Revvity Inc trades at $109.79 (market cap $12.33B). The key difference: Revvity Inc is far larger — about 2.1× Transocean Ltd's market cap, and Revvity Inc pays a 0.25% dividend while Transocean Ltd pays none. Which is the better fit depends on your goals.
| RIG | RVTY | |
|---|---|---|
Market Cap | $5.80B | $12.33B |
Sector | Technology | Technology |
52-Week High | $7.58 | $117.75 |
52-Week Low | $2.80 | $82.26 |
Enterprise Value | $10.74B | $14.82B |
Dividend Yield | — | 0.25% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Transocean Ltd. (RIG) trades at $5.02, down 2.33% today, reflecting ongoing investor caution despite recent contract wins. The stock shows a bearish technical bias with moving averages signaling sell pressure, while fundamentals reveal persistent net losses (-$2.92B in 2025) despite high gross margins (84.88%). Recent news highlights a $1B+ Equinor contract and pending Valaris merger, boosting long-term revenue visibility but failing to offset near-term profitability concerns.
RIG's investment case hinges on backlog execution and merger synergies, offering potential upside to the $7.00 consensus target. However, high leverage, volatile oil prices, and consecutive earnings misses pose significant risks. Analyst sentiment is divided (39% Buy, 39% Hold), suggesting cautious optimism amid operational challenges.
RVTY trades at $106.44, down 3.37% today, with a bullish technical outlook despite near-term weakness. The company maintains stable revenue around $2.9B with consistent earnings beats, though valuation multiples appear elevated with a P/E of 51. Recent AI product launches and FDA clearances demonstrate innovation in life sciences and diagnostics. Analyst consensus remains positive with a $111.43 price target and no sell ratings among 29 covering firms.
The stock presents a growth opportunity with strong analyst support and technological innovation, but faces risks from margin pressure and China market exposure. Current levels near support at $105 offer potential entry, though the high P/E requires sustained earnings growth to justify valuation. Upcoming Q2 earnings on August 4, 2026 will be critical for near-term direction.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Transocean Ltd
Transocean Ltd. is a leading international provider of offshore contract drilling services for oil and gas wells. The company operates one of the world's most versatile fleets of mobile offshore drilling units, including ultra-deepwater drillships and harsh environment semi-submersibles. RIG's services are essential to energy exploration and production companies seeking to access deepwater and challenging reserves globally.
Read more on RIG →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
